Investigating Participation Patterns Among Stage IV Melanoma Patients
ConditionStage IV Melanoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged ≥ 18 years old
Diagnosis of stage IV melanoma
Able to comprehend the investigational nature of the protocol and provide informed consent
Disqualifiers
Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting
Trial population
Patients with stage IV melanoma who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of stage IV melanoma patients who decide to enroll in a clinical research
Time frame
3 months2
Rate of stage IV melanoma patients who remain in clinical trial to trial completion
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: